Azienda Ospedaliera Di Padova
Welcome,         Profile    Billing    Logout  
 46 Trials 
49 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cillo, Umberto
SONAR, NCT06690528: Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver

Recruiting
2
56
Europe
Surgical resection of both the primary tumor and liver metastases
Azienda Ospedaliera di Padova, University of Padova
Pancreatic Cancer Metastatic
11/28
11/28
Over70-LT, NCT06382740: Selection Protocol for Liver Transplantation in Patients Aged Over 70 Years

Recruiting
N/A
18
Europe
Liver transplantation
Azienda Ospedaliera di Padova
End Stage Liver DIsease, Liver Transplantation, Old Age
10/25
10/25
ORCHESTRA-4, NCT05222139: Monitoring COVID-19 Vaccination Response in Fragile Populations

Completed
N/A
8894
Europe, RoW
COVID-19 vaccination
University of Bologna, Universita di Verona, Hospital Universitario Virgen Macarena, Azienda Ospedaliera di Padova, Azienda Ospedaliero-Universitaria di Parma, Azienda Ulss 2 Marca Trevigiana, University College Dublin, Luxembourg Institute of Health, ICONA Foundation, University Medical Center Groningen, University of Buenos Aires, PENTA Foundation, Universiteit Antwerpen, Institut National de la Santé Et de la Recherche Médicale, France, Helmholtz Zentrum München, CINECA consorzio universitario italiano, Charite University, Berlin, Germany, Centre de Recherche Médicale de Lambaréné
SARS CoV 2 Infection, Vaccination; Infection, Breakthrough Infection
07/23
11/24
LIVACOR, NCT05138094: Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection

Recruiting
N/A
82
Europe, RoW
Minimally invasive simultaneous resection, Minimally invasive combined resection, Minimally invasive synchronous resection, Minimally invasive two-stage resection, Minimally invasive sequential resection
Fondazione Poliambulanza Istituto Ospedaliero, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University Hospital Southampton NHS Foundation Trust, University Hospital Birmingham NHS Foundation Trust, Liverpool University Hospitals NHS Foundation Trust, King's College Hospital NHS Trust, Manchester University NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, University Hospital Plymouth NHS Trust, Mauriziano Umberto I Hospital, University Hospital Padova, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, San Raffaele University Hospital, Italy, Ospedali Riuniti Ancona, Azienda Usl di Bologna, Azienda Ospedaliero-Universitaria di Modena, Federico II University, Parma University Hospital, Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie, Maastricht University Medical Center, University of Navarrra Hospital (Clinica Universitaria), Hospital del Mar, Assistance Publique - Hôpitaux de Paris, Oslo University Hospital, Ziekenhuis Oost-Limburg, General Hospital Groeninge, Moscow Clinical Scientific Center, Centre Hospitalier du Luxembourg
Colorectal Neoplasms Malignant, Neoplasm Metastasis
09/23
09/24
ROBOCHOL, NCT06720883: Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study

Recruiting
N/A
32
Europe
Major hepatectomy
Azienda Ospedaliera di Padova
Cholangiocarcinoma Cancer, Perihilar Cholangiocarcinoma
07/27
07/31
MELODIC, NCT04870879: Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors

Recruiting
N/A
18
Europe
Liver Transplant, Chemotherapy
Azienda Ospedaliera di Padova, Istituto Oncologico Veneto IRCCS
Colorectal Liver Metastases, Colorectal Adenocarcinoma, Unresectable Malignant Neoplasm
10/25
10/25
RAPID-Padova, NCT04865471: Resection And Partial Liver Segmental Transplantation With Delayed Total Hepatectomy

Recruiting
N/A
18
Europe
Liver transplantation
Azienda Ospedaliera di Padova, Istituto Oncologico Veneto IRCCS
Liver Metastases
10/25
10/25
LIRICA, NCT06098547: LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Intrahepatic Cholangiocarcinoma
11/28
11/33
LITALHICA, NCT06125769: LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Perihilar Cholangiocarcinoma
11/28
11/33
Tarantini, Giuseppe
FIL_PREVID, NCT04442412 / 2019-004474-26: Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

Recruiting
3
430
Europe
Vitamin D3 (Cholecalciferol), RCHOP o R-miniCHOP at standard doses
Fondazione Italiana Linfomi ONLUS, GRADE Onlus
Diffuse Large B-Cell Lymphoma, Elderly Patients
09/25
09/30
FIL_FOLL19, NCT05058404: Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

Recruiting
3
602
Europe
Immunochemotherapy regimen: Rituximab-bendamustine (Arm A), R-Benda, R-bendamustine, Immunochemotherapy regimen: Rituximab-bendamustine (Arm B), Immunochemotherapy regimen: R-CHOP (Arm A), R-CHOP, Immunochemotherapy regimen: R-CHOP (Arm B), Immunochemotherapy regimen: G-bendamustine (Arm A), G-Benda, Immunochemotherapy regimen: G-bendamustine (Arm B), Immunochemotherapy regimen: G-CHOP (Arm A), G-CHOP, Immunochemotherapy regimen: G-CHOP (Arm B), Immunochemotherapy regimen: G-CVP (Arm A), G-CVP, Immunochemotherapy regimen: G-CVP (Arm B)
Fondazione Italiana Linfomi - ETS
Follicular Lymphoma
07/28
07/30
FIL_Copa-RB, NCT04433182 / 2019-004898-63: Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma

Terminated
2
37
Europe
Copanlisib, ALIQOPA
Fondazione Italiana Linfomi - ETS
Diffuse Large B-cell Lymphoma
12/24
12/24
GIOTTO, NCT03521921: GIse Registry Of Transcatheter Treatment of Mitral Valve regurgitaTiOn

Active, not recruiting
N/A
1500
Europe
Mitraclip
IRCCS Policlinico S. Donato
Mitral Regurgitation
02/21
09/25
1621-QLG-LG, NCT03755856: Long-term Outcomes for Acute Myeloid Leukemia Patients

Recruiting
N/A
343
Europe, RoW
Questionnaire
Gruppo Italiano Malattie EMatologiche dell'Adulto, European Organisation for Research and Treatment of Cancer - EORTC
Acute Myeloid Leukemia
06/21
12/22
CAvEAT, NCT04647864: The Coronary AccEss After Tavi Registry - A Multicenter Prospective Registry for the Coronary Access After TAVI

Recruiting
N/A
600
Europe
Transcatheter Aortic Valve Implantation, Transcatheter Aortic Valve Replacement, Percutaneous aortic valve replacement (PAVR), Percutaneous aortic valve implantation (PAVI)
University of Padova, Fondazione GISE Onlus
Aortic Valve Disease
06/22
12/22
NCT04581187: An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies

Recruiting
N/A
400
Europe
Quality of life assessment
Gruppo Italiano Malattie EMatologiche dell'Adulto
Hematologic Malignancies
12/22
12/24
EUROSHOCK, NCT03813134: Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

Recruiting
N/A
428
Europe
Percutaneous coronary intervention (PCI), Pharmacological Support, VA-ECMO, Veno-Arterial Extra Corporeal Membrane Oxygenation.
University of Leicester, European Commission, University of Glasgow, KU Leuven, University of East Anglia, Deutsches Herzzentrum Muenchen, A.O. Ospedale Papa Giovanni XXIII, Chalice Medical Ltd, Ludwig-Maximilians - University of Munich, University of Tromso, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Paula Stradina Liniska Universitates, Accelopment AG, Universiteit Antwerpen, Cardiovascular European Research Centre (CERC)
Cardiogenic Shock
03/23
02/24
NCT04280029: SELUTION SLR™ 014 In-stent Restenosis

Active, not recruiting
N/A
418
Europe, Canada, US, RoW
SELUTION SLR™ DEB, Control
M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation
Coronary Restenosis
07/25
08/29
NCT05844969: Circle Method Observational Project - Non-interventional, Retrospective, Multicenter Data Collection

Not yet recruiting
N/A
60
Europe
Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences
Aortic Stenosis with Bicuspid Valve
08/25
08/25
NCT06299553: Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

Recruiting
N/A
200
Europe
Incyte Biosciences Italy S.r.l, Advice Pharma Group srl
DLBCL - Diffuse Large B Cell Lymphoma
06/25
06/27
TARGET FIRST, NCT04753749 / 2020-005933-34: Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

Active, not recruiting
N/A
2248
Europe
Shortened DAPT followed by P2Y12 inhibitor monotherapy (cessation of aspirin), Standard DAPT
MicroPort CRM, European Cardiovascular Research Center
Myocardial Infarction, Acute, Coronary Artery Disease
04/25
04/25
VANTAGE, NCT04788888: Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

Recruiting
N/A
590
Europe, RoW
Navitor Transcatheter Aortic Valve and FlexNav Delivery System
Abbott Medical Devices
Symptomatic Severe Aortic Stenosis
06/25
02/36
NCT05601453: The ReTAVI Prospective Observational Registry

Recruiting
N/A
150
Europe, Canada, RoW
Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI, redo-TAVR, Valve-in-Valve (ViV), TAV-in-TAV, TAVR-in-TAVR, Revalve
Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences
Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction, Prosthesis Failure
09/25
12/26
NCT03552003: Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis

Recruiting
N/A
400
Europe
Treatment for clinical practise
Fondazione Italiana Linfomi ONLUS
Classical Hodgkin Lymphoma
01/26
01/26
NCT05934084: Lifestyles Implemented-Survivorship Care Plan in Lymphoma Survivors

Recruiting
N/A
552
Europe
Lifestyles Implemented-Survivorship Care Plan (LS-SCP)
Fondazione Italiana Linfomi - ETS
Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL)
02/26
02/26
FIL_MAB, NCT06008691: A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

Recruiting
N/A
1500
Europe
"novel" MAB (alone or in combination)
Fondazione Italiana Linfomi - ETS, Roche Pharma AG
Non-Hodgkin Lymphoma, B-cell
10/38
10/38
Zanus, Giacomo
HERCOLES2, NCT04053231: Hepatocarcinoma Recurrence on the Liver Study - Part2

Not yet recruiting
N/A
3000
Europe
liver resection
University of Milano Bicocca
Liver Cancer, Surgery, Recurrence Tumor, Cirrhosis
09/22
05/34
Gringeri, Enrico
LIVACOR, NCT05138094: Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection

Recruiting
N/A
82
Europe, RoW
Minimally invasive simultaneous resection, Minimally invasive combined resection, Minimally invasive synchronous resection, Minimally invasive two-stage resection, Minimally invasive sequential resection
Fondazione Poliambulanza Istituto Ospedaliero, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University Hospital Southampton NHS Foundation Trust, University Hospital Birmingham NHS Foundation Trust, Liverpool University Hospitals NHS Foundation Trust, King's College Hospital NHS Trust, Manchester University NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, University Hospital Plymouth NHS Trust, Mauriziano Umberto I Hospital, University Hospital Padova, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, San Raffaele University Hospital, Italy, Ospedali Riuniti Ancona, Azienda Usl di Bologna, Azienda Ospedaliero-Universitaria di Modena, Federico II University, Parma University Hospital, Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie, Maastricht University Medical Center, University of Navarrra Hospital (Clinica Universitaria), Hospital del Mar, Assistance Publique - Hôpitaux de Paris, Oslo University Hospital, Ziekenhuis Oost-Limburg, General Hospital Groeninge, Moscow Clinical Scientific Center, Centre Hospitalier du Luxembourg
Colorectal Neoplasms Malignant, Neoplasm Metastasis
09/23
09/24
ROBOCHOL, NCT06720883: Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study

Recruiting
N/A
32
Europe
Major hepatectomy
Azienda Ospedaliera di Padova
Cholangiocarcinoma Cancer, Perihilar Cholangiocarcinoma
07/27
07/31
LIRICA, NCT06098547: LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Intrahepatic Cholangiocarcinoma
11/28
11/33
LITALHICA, NCT06125769: LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Perihilar Cholangiocarcinoma
11/28
11/33
D'Amico, Francesco
ROBOCHOL, NCT06720883: Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study

Recruiting
N/A
32
Europe
Major hepatectomy
Azienda Ospedaliera di Padova
Cholangiocarcinoma Cancer, Perihilar Cholangiocarcinoma
07/27
07/31
LIRICA, NCT06098547: LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Intrahepatic Cholangiocarcinoma
11/28
11/33
LITALHICA, NCT06125769: LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Perihilar Cholangiocarcinoma
11/28
11/33
Vitale, Alessandro
LIRICA, NCT06098547: LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Intrahepatic Cholangiocarcinoma
11/28
11/33
LITALHICA, NCT06125769: LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Perihilar Cholangiocarcinoma
11/28
11/33
Giannini, Sandro
NCT06826664: Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism

Not yet recruiting
N/A
100
Europe
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Phosphate Deficiency, Phosphate Overload
05/35
05/35
XLHRegistry, NCT03193476: Registry for Patients With X-Linked Hypophosphatemia

Recruiting
N/A
1343
Europe, RoW
Kyowa Kirin Pharmaceutical Development Ltd, Iqvia Pty Ltd
X-Linked Hypophosphatemia
02/29
07/29
Matute, W Giron
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Martínez, JM Cifrian
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Ferguson, K
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Putla, S
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Bella, Vincenzo La
STEMALS, NCT06344260: Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis

Recruiting
2
30
Europe
human Neural Stem Cells (hNSC), Injection of human neural stem cells into brain lateral ventricle, Saline (Placebo), Injection of saline into brain lateral ventricle
Casa Sollievo della Sofferenza IRCCS, Ministry of Health, Italy
Amyotrophic Lateral Sclerosis
03/27
09/27
Wijsenbeek-Lourens, M
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Necki, M
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Molina-Molina, M
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Tulek, B
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Rijswijk, R van
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Damps-Konstanska, I
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cillo, Umberto
SONAR, NCT06690528: Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver

Recruiting
2
56
Europe
Surgical resection of both the primary tumor and liver metastases
Azienda Ospedaliera di Padova, University of Padova
Pancreatic Cancer Metastatic
11/28
11/28
Over70-LT, NCT06382740: Selection Protocol for Liver Transplantation in Patients Aged Over 70 Years

Recruiting
N/A
18
Europe
Liver transplantation
Azienda Ospedaliera di Padova
End Stage Liver DIsease, Liver Transplantation, Old Age
10/25
10/25
ORCHESTRA-4, NCT05222139: Monitoring COVID-19 Vaccination Response in Fragile Populations

Completed
N/A
8894
Europe, RoW
COVID-19 vaccination
University of Bologna, Universita di Verona, Hospital Universitario Virgen Macarena, Azienda Ospedaliera di Padova, Azienda Ospedaliero-Universitaria di Parma, Azienda Ulss 2 Marca Trevigiana, University College Dublin, Luxembourg Institute of Health, ICONA Foundation, University Medical Center Groningen, University of Buenos Aires, PENTA Foundation, Universiteit Antwerpen, Institut National de la Santé Et de la Recherche Médicale, France, Helmholtz Zentrum München, CINECA consorzio universitario italiano, Charite University, Berlin, Germany, Centre de Recherche Médicale de Lambaréné
SARS CoV 2 Infection, Vaccination; Infection, Breakthrough Infection
07/23
11/24
LIVACOR, NCT05138094: Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection

Recruiting
N/A
82
Europe, RoW
Minimally invasive simultaneous resection, Minimally invasive combined resection, Minimally invasive synchronous resection, Minimally invasive two-stage resection, Minimally invasive sequential resection
Fondazione Poliambulanza Istituto Ospedaliero, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University Hospital Southampton NHS Foundation Trust, University Hospital Birmingham NHS Foundation Trust, Liverpool University Hospitals NHS Foundation Trust, King's College Hospital NHS Trust, Manchester University NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, University Hospital Plymouth NHS Trust, Mauriziano Umberto I Hospital, University Hospital Padova, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, San Raffaele University Hospital, Italy, Ospedali Riuniti Ancona, Azienda Usl di Bologna, Azienda Ospedaliero-Universitaria di Modena, Federico II University, Parma University Hospital, Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie, Maastricht University Medical Center, University of Navarrra Hospital (Clinica Universitaria), Hospital del Mar, Assistance Publique - Hôpitaux de Paris, Oslo University Hospital, Ziekenhuis Oost-Limburg, General Hospital Groeninge, Moscow Clinical Scientific Center, Centre Hospitalier du Luxembourg
Colorectal Neoplasms Malignant, Neoplasm Metastasis
09/23
09/24
ROBOCHOL, NCT06720883: Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study

Recruiting
N/A
32
Europe
Major hepatectomy
Azienda Ospedaliera di Padova
Cholangiocarcinoma Cancer, Perihilar Cholangiocarcinoma
07/27
07/31
MELODIC, NCT04870879: Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors

Recruiting
N/A
18
Europe
Liver Transplant, Chemotherapy
Azienda Ospedaliera di Padova, Istituto Oncologico Veneto IRCCS
Colorectal Liver Metastases, Colorectal Adenocarcinoma, Unresectable Malignant Neoplasm
10/25
10/25
RAPID-Padova, NCT04865471: Resection And Partial Liver Segmental Transplantation With Delayed Total Hepatectomy

Recruiting
N/A
18
Europe
Liver transplantation
Azienda Ospedaliera di Padova, Istituto Oncologico Veneto IRCCS
Liver Metastases
10/25
10/25
LIRICA, NCT06098547: LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Intrahepatic Cholangiocarcinoma
11/28
11/33
LITALHICA, NCT06125769: LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Perihilar Cholangiocarcinoma
11/28
11/33
Tarantini, Giuseppe
FIL_PREVID, NCT04442412 / 2019-004474-26: Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

Recruiting
3
430
Europe
Vitamin D3 (Cholecalciferol), RCHOP o R-miniCHOP at standard doses
Fondazione Italiana Linfomi ONLUS, GRADE Onlus
Diffuse Large B-Cell Lymphoma, Elderly Patients
09/25
09/30
FIL_FOLL19, NCT05058404: Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

Recruiting
3
602
Europe
Immunochemotherapy regimen: Rituximab-bendamustine (Arm A), R-Benda, R-bendamustine, Immunochemotherapy regimen: Rituximab-bendamustine (Arm B), Immunochemotherapy regimen: R-CHOP (Arm A), R-CHOP, Immunochemotherapy regimen: R-CHOP (Arm B), Immunochemotherapy regimen: G-bendamustine (Arm A), G-Benda, Immunochemotherapy regimen: G-bendamustine (Arm B), Immunochemotherapy regimen: G-CHOP (Arm A), G-CHOP, Immunochemotherapy regimen: G-CHOP (Arm B), Immunochemotherapy regimen: G-CVP (Arm A), G-CVP, Immunochemotherapy regimen: G-CVP (Arm B)
Fondazione Italiana Linfomi - ETS
Follicular Lymphoma
07/28
07/30
FIL_Copa-RB, NCT04433182 / 2019-004898-63: Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma

Terminated
2
37
Europe
Copanlisib, ALIQOPA
Fondazione Italiana Linfomi - ETS
Diffuse Large B-cell Lymphoma
12/24
12/24
GIOTTO, NCT03521921: GIse Registry Of Transcatheter Treatment of Mitral Valve regurgitaTiOn

Active, not recruiting
N/A
1500
Europe
Mitraclip
IRCCS Policlinico S. Donato
Mitral Regurgitation
02/21
09/25
1621-QLG-LG, NCT03755856: Long-term Outcomes for Acute Myeloid Leukemia Patients

Recruiting
N/A
343
Europe, RoW
Questionnaire
Gruppo Italiano Malattie EMatologiche dell'Adulto, European Organisation for Research and Treatment of Cancer - EORTC
Acute Myeloid Leukemia
06/21
12/22
CAvEAT, NCT04647864: The Coronary AccEss After Tavi Registry - A Multicenter Prospective Registry for the Coronary Access After TAVI

Recruiting
N/A
600
Europe
Transcatheter Aortic Valve Implantation, Transcatheter Aortic Valve Replacement, Percutaneous aortic valve replacement (PAVR), Percutaneous aortic valve implantation (PAVI)
University of Padova, Fondazione GISE Onlus
Aortic Valve Disease
06/22
12/22
NCT04581187: An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies

Recruiting
N/A
400
Europe
Quality of life assessment
Gruppo Italiano Malattie EMatologiche dell'Adulto
Hematologic Malignancies
12/22
12/24
EUROSHOCK, NCT03813134: Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

Recruiting
N/A
428
Europe
Percutaneous coronary intervention (PCI), Pharmacological Support, VA-ECMO, Veno-Arterial Extra Corporeal Membrane Oxygenation.
University of Leicester, European Commission, University of Glasgow, KU Leuven, University of East Anglia, Deutsches Herzzentrum Muenchen, A.O. Ospedale Papa Giovanni XXIII, Chalice Medical Ltd, Ludwig-Maximilians - University of Munich, University of Tromso, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Paula Stradina Liniska Universitates, Accelopment AG, Universiteit Antwerpen, Cardiovascular European Research Centre (CERC)
Cardiogenic Shock
03/23
02/24
NCT04280029: SELUTION SLR™ 014 In-stent Restenosis

Active, not recruiting
N/A
418
Europe, Canada, US, RoW
SELUTION SLR™ DEB, Control
M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation
Coronary Restenosis
07/25
08/29
NCT05844969: Circle Method Observational Project - Non-interventional, Retrospective, Multicenter Data Collection

Not yet recruiting
N/A
60
Europe
Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences
Aortic Stenosis with Bicuspid Valve
08/25
08/25
NCT06299553: Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

Recruiting
N/A
200
Europe
Incyte Biosciences Italy S.r.l, Advice Pharma Group srl
DLBCL - Diffuse Large B Cell Lymphoma
06/25
06/27
TARGET FIRST, NCT04753749 / 2020-005933-34: Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

Active, not recruiting
N/A
2248
Europe
Shortened DAPT followed by P2Y12 inhibitor monotherapy (cessation of aspirin), Standard DAPT
MicroPort CRM, European Cardiovascular Research Center
Myocardial Infarction, Acute, Coronary Artery Disease
04/25
04/25
VANTAGE, NCT04788888: Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

Recruiting
N/A
590
Europe, RoW
Navitor Transcatheter Aortic Valve and FlexNav Delivery System
Abbott Medical Devices
Symptomatic Severe Aortic Stenosis
06/25
02/36
NCT05601453: The ReTAVI Prospective Observational Registry

Recruiting
N/A
150
Europe, Canada, RoW
Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI, redo-TAVR, Valve-in-Valve (ViV), TAV-in-TAV, TAVR-in-TAVR, Revalve
Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences
Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction, Prosthesis Failure
09/25
12/26
NCT03552003: Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis

Recruiting
N/A
400
Europe
Treatment for clinical practise
Fondazione Italiana Linfomi ONLUS
Classical Hodgkin Lymphoma
01/26
01/26
NCT05934084: Lifestyles Implemented-Survivorship Care Plan in Lymphoma Survivors

Recruiting
N/A
552
Europe
Lifestyles Implemented-Survivorship Care Plan (LS-SCP)
Fondazione Italiana Linfomi - ETS
Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL)
02/26
02/26
FIL_MAB, NCT06008691: A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

Recruiting
N/A
1500
Europe
"novel" MAB (alone or in combination)
Fondazione Italiana Linfomi - ETS, Roche Pharma AG
Non-Hodgkin Lymphoma, B-cell
10/38
10/38
Zanus, Giacomo
HERCOLES2, NCT04053231: Hepatocarcinoma Recurrence on the Liver Study - Part2

Not yet recruiting
N/A
3000
Europe
liver resection
University of Milano Bicocca
Liver Cancer, Surgery, Recurrence Tumor, Cirrhosis
09/22
05/34
Gringeri, Enrico
LIVACOR, NCT05138094: Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection

Recruiting
N/A
82
Europe, RoW
Minimally invasive simultaneous resection, Minimally invasive combined resection, Minimally invasive synchronous resection, Minimally invasive two-stage resection, Minimally invasive sequential resection
Fondazione Poliambulanza Istituto Ospedaliero, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University Hospital Southampton NHS Foundation Trust, University Hospital Birmingham NHS Foundation Trust, Liverpool University Hospitals NHS Foundation Trust, King's College Hospital NHS Trust, Manchester University NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, University Hospital Plymouth NHS Trust, Mauriziano Umberto I Hospital, University Hospital Padova, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, San Raffaele University Hospital, Italy, Ospedali Riuniti Ancona, Azienda Usl di Bologna, Azienda Ospedaliero-Universitaria di Modena, Federico II University, Parma University Hospital, Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie, Maastricht University Medical Center, University of Navarrra Hospital (Clinica Universitaria), Hospital del Mar, Assistance Publique - Hôpitaux de Paris, Oslo University Hospital, Ziekenhuis Oost-Limburg, General Hospital Groeninge, Moscow Clinical Scientific Center, Centre Hospitalier du Luxembourg
Colorectal Neoplasms Malignant, Neoplasm Metastasis
09/23
09/24
ROBOCHOL, NCT06720883: Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study

Recruiting
N/A
32
Europe
Major hepatectomy
Azienda Ospedaliera di Padova
Cholangiocarcinoma Cancer, Perihilar Cholangiocarcinoma
07/27
07/31
LIRICA, NCT06098547: LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Intrahepatic Cholangiocarcinoma
11/28
11/33
LITALHICA, NCT06125769: LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Perihilar Cholangiocarcinoma
11/28
11/33
D'Amico, Francesco
ROBOCHOL, NCT06720883: Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study

Recruiting
N/A
32
Europe
Major hepatectomy
Azienda Ospedaliera di Padova
Cholangiocarcinoma Cancer, Perihilar Cholangiocarcinoma
07/27
07/31
LIRICA, NCT06098547: LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Intrahepatic Cholangiocarcinoma
11/28
11/33
LITALHICA, NCT06125769: LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Perihilar Cholangiocarcinoma
11/28
11/33
Vitale, Alessandro
LIRICA, NCT06098547: LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Intrahepatic Cholangiocarcinoma
11/28
11/33
LITALHICA, NCT06125769: LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma

Recruiting
N/A
10
Europe
Liver transplantation
Azienda Sanitaria Ospedaliera, Istituto Oncologico Veneto IRCCS
Perihilar Cholangiocarcinoma
11/28
11/33
Giannini, Sandro
NCT06826664: Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism

Not yet recruiting
N/A
100
Europe
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Phosphate Deficiency, Phosphate Overload
05/35
05/35
XLHRegistry, NCT03193476: Registry for Patients With X-Linked Hypophosphatemia

Recruiting
N/A
1343
Europe, RoW
Kyowa Kirin Pharmaceutical Development Ltd, Iqvia Pty Ltd
X-Linked Hypophosphatemia
02/29
07/29
Matute, W Giron
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Martínez, JM Cifrian
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Ferguson, K
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Putla, S
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Bella, Vincenzo La
STEMALS, NCT06344260: Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis

Recruiting
2
30
Europe
human Neural Stem Cells (hNSC), Injection of human neural stem cells into brain lateral ventricle, Saline (Placebo), Injection of saline into brain lateral ventricle
Casa Sollievo della Sofferenza IRCCS, Ministry of Health, Italy
Amyotrophic Lateral Sclerosis
03/27
09/27
Wijsenbeek-Lourens, M
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Necki, M
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Molina-Molina, M
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Tulek, B
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Rijswijk, R van
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25
Damps-Konstanska, I
CORAL, NCT05964335: Cough Reduction in IPF with Nalbuphine ER

Recruiting
2
160
Europe, Canada, RoW
nalbuphine ER 27 mg, Active, Placebo, nalbuphine ER 54 mg, nalbuphine ER 108 mg
Trevi Therapeutics
Idiopathic Pulmonary Fibrosis
04/25
04/25

Download Options